2018 Rosenman Innovator company, Candesant Biomedical is a clinical stage company focused on development of a novel treatment for the non-invasive treatment of excessive sweating or hyperhidrosis. The company’s lead investigational product is a topical patch to conveniently treat excessive sweating with a quick, in-office procedure. Two successful clinical studies demonstrated efficacy in reducing sweat and validated that the energy is reproducibly generated, highly targeted and appears to inactivate the most active sweat glands. In these initial clinical studies, Candesant’s investigational treatment demonstrated significant sweat reduction benefits lasting up to 2 months after a single, no down-time treatment.
